- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
Painful, Itchy Patches Could Be Sign of Skin Cancer
Painful or itchy skin lesions could be a warning sign of skin cancer, researchers report.
“Patients sometimes have multiple lesions that are suspicious looking, and those that are itchy or painful should raise high concerns for non-melanoma skin cancers,” study author Dr. Gil Yosipovitch, chairman of dermatology at Temple University School of Medicine, said in a Temple University Health System news release.
Researchers looked at the medical records of 268 patients who were confirmed to have skin cancer lesions between 2010 and 2011. The patients were treated at Wake Forest University Baptist Medical Center and had almost 350 lesions in total.
The patients answered questions about the levels of pain and itchiness in their lesions. More than one-third of the skin cancer lesions itched, according to the study. Just under 30 percent were painful. Many people reported that their lesions were both painful and itchy.
Melanoma lesions were the least likely to be painful or itchy. Other skin cancers, especially basal cell carcinoma and squamous cell carcinoma, were more likely to be itchy or painful, the findings showed. Melanoma is much less common than basal cell and squamous cell skin cancers, but it is far more dangerous, according to the American Cancer Society.
“The study highlights the importance of a simple bedside evaluation for the presence and intensity of pain or itch as an easily implementable tool for clinicians in evaluating suspicious skin lesions,” the study authors wrote.
Yosipovitch hopes the study will encourage the development of a ranking scale to help doctors use the symptoms of pain or itch — or both — to figure out whether patients have skin cancer.
The study appears in the July 23 issue of JAMA Dermatology.
More information
For more about skin cancer, visit the U.S. National Cancer Institute.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.